116 Results for “Coronavirus%20Means”
-
Article
Coronavirus Perceptions and Economic Anxiety
Jul 28, 2020
When people recognize just how dangerous covid is, they worry more about the economy
-
News
INET Board Member Richard Vague on Rescuing the Coronavirus Economy
Apr 1, 2020
INET Board Member Richard Vague writes in The Hill on how to rescue the coronavirus economy
-
Podcasts
Peter Bofinger
May 7, 2020
Peter Bofinger, an economist and former member of Germany’s Council of Economic Experts, talks to Rob about the economic crisis now facing Europe, how Modern Monetary Theory could address it, and how it differs from the Great Recession of 2008. Mentioned in the interview: https://www.youtube.com/watch?v=bNgQRs8nY4chttps://www.socialeurope.eu/coronavirus-crisis-now-is-the-hour-of-modern-monetary-theory
-
Article
Coronavirus Means Zero Hour for the European Union
Mar 16, 2020
If the European Central Bank does not jump to the aid of peripheral countries weakened by the pandemic, the Eurozone could collapse.
-
Video
How Lifting Intellectual Property Restrictions Could Help World Vaccinate 60% of Population by 2022
Apr 29, 2021
As new coronavirus cases surge across India, calls are growing louder for wealthy countries to loosen intellectual property restrictions
-
Article
4 Charts Explain Why You Should Worry About the New U.K. Covid Strain
Jan 13, 2021
Expert warns that it could be a race against the clock as the fast-spreading B117 variant picks up steam in the U.S.
-
News
William Lazonick is quoted in on the stock market practices of Big Pharma
Oct 29, 2020
“Executives have an interest in getting the stock price up and price gouging customers is one way they can do this,” said William Lazonick, professor emeritus of economics at University of Massachusetts and co-founder of the Academic-Industry Research Network. While many drug companies argue that they use their vast profits to fund ongoing pharmaceutical innovation, Lazonick said, “we’ve shown that most of these companies don’t do that.” Instead, the soaring prices fuel soaring stock prices and executive pay, which is often based largely on that price.” — INET Grantee William Lazonick
-
Video
Why We Need Solidarity Economics
Apr 22, 2020
Economists have gone to great lengths to write humans out of economics, pushing self-interest and generally providing two choices—faith in markets or the state.
-
Podcasts
Naomi Klein & Avi Lews
May 12, 2020
Rob talks to activist and author Naomi Klein and to documentarian Avi Lewis about how the pandemic has spurred the “shock doctrine”: the sudden imposition of neoliberalism and austerity in response to a crisis. They also discuss the possibilities of a new international solidarity around a global Green New Deal.
-
Article
To Save the Economy, Save People First
Nov 18, 2020
Targeted Measures and Subsidies for Cost Effective COVID-19 Abatement
-
Article
Enhancing Resilience in African Economies: Policy Responses to the COVID19 Pandemic in Africa
Jun 3, 2020
An introduction to a series of interviews conducted by Dr. Dr. Folashadé Soulé and Dr. Camilla Toulmin in support of INET’s Commission on Global Economic Transformation (CGET)
-
Webinars and Events
Extreme Climate Change in a Post-COVID 19 World
Webinarwith Geoff Mann | 1:00pm ET / 10:00am PT
Apr 29, 2020
Please join us for a discussion with Geoff Mann, INET Senior Fellow and author of Climate Leviathan: A Political Theory of Our Planetary Future, on how the coronavirus pandemic might (or might not) teach us to prepare for a life on an increasingly hot planet.
-
Article
Which Businesses Will Covid-19 Disrupt and Why? An Assessment Based on Firm-Level Data
Apr 2, 2020
The scale of firm exposure to the coronavirus is unprecedented by earlier outbreaks, spans all major economies and is pervasive across all industries
-
Article
America’s Chilling Experiment in Human Sacrifice
May 14, 2020
John Ruskin helps shed light on what it means to have an economy that demands we die for it
-
Working Paper
Working Paper SeriesGovernment as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019
Sep 2020
Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019